Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
4.780
+0.360 (8.14%)
Jul 31, 2026, 7:48 AM EDT - Market open
Zepp Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 70 | 395 | 38 | 1,368 | 1,423 | 317 | |
Market Cap Growth | -68.14% | 949.11% | -97.24% | -3.87% | 348.68% | -97.32% |
Enterprise Value | 140.75 | 566.47 | 127.55 | 1,423 | 1,535 | 282.53 |
Last Close Price | 4.78 | 26.94 | 2.60 | 5.68 | 5.80 | 20.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 15.42 |
Forward PE | - | 14.00 | 14.00 | 11.83 | 8.54 | 6.96 |
PS Ratio | 0.24 | 1.53 | 0.21 | 3.88 | 2.32 | 0.32 |
PB Ratio | 0.36 | 1.84 | 0.15 | 3.90 | 3.67 | 0.69 |
P/TBV Ratio | 0.45 | 2.24 | 0.18 | 0.26 | 0.25 | 0.78 |
P/FCF Ratio | - | - | - | 33.36 | - | - |
P/OCF Ratio | - | - | - | 32.11 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.52 | 2.19 | 0.70 | 4.03 | 2.50 | 0.29 |
EV/EBITDA Ratio | - | - | - | - | - | 12.31 |
EV/EBIT Ratio | - | - | - | - | - | 19.12 |
EV/FCF Ratio | - | - | - | 34.70 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.23 | 1.06 | 0.72 | 0.54 | 0.63 | 0.43 |
Debt / EBITDA Ratio | - | - | - | - | - | 8.64 |
Debt / FCF Ratio | - | - | - | 4.68 | - | - |
Net Debt / Equity Ratio | 0.96 | 0.80 | 0.35 | 0.15 | 0.29 | -0.08 |
Net Debt / EBITDA Ratio | -6.55 | -6.92 | -2.10 | -2.33 | -2.08 | -1.60 |
Net Debt / FCF Ratio | - | -6.52 | -3.44 | 1.29 | -0.93 | 0.84 |
Asset Turnover | 0.50 | 0.47 | 0.31 | 0.50 | 0.71 | 1.06 |
Inventory Turnover | 2.24 | 2.47 | 1.59 | 2.24 | 2.87 | 4.06 |
Quick Ratio | 0.39 | 0.46 | 0.81 | 1.34 | 1.04 | 1.08 |
Current Ratio | 0.88 | 1.02 | 1.29 | 2.04 | 1.77 | 1.83 |
Return on Equity (ROE) | -18.51% | -17.15% | -25.04% | -8.38% | -10.19% | 4.90% |
Return on Assets (ROA) | -5.59% | -5.73% | -10.04% | -4.05% | -5.92% | 1.43% |
Return on Invested Capital (ROIC) | -8.00% | -8.62% | -15.64% | -6.25% | -11.02% | 4.46% |
Return on Capital Employed (ROCE) | -11.06% | -9.56% | -11.61% | -6.08% | -10.85% | 2.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | - | - | - | 6.49% |
FCF Yield | - | - | - | 3.00% | - | - |
Dividend Yield | - | 0.00% | 0.00% | 0.00% | 7.06% | 0.00% |
Payout Ratio | - | 0.00% | 0.00% | 0.00% | -14.58% | 0.00% |
Buyback Yield / Dilution | 1.66% | 1.72% | -6.47% | 1.28% | 6.84% | -1.54% |
Total Shareholder Return | 1.66% | 1.72% | -6.47% | 1.28% | 13.90% | -1.54% |